Ergoloid mesylates - Generic Drug Details

✉ Email this page to a colleague

What are the generic sources for ergoloid mesylates and what is the scope of freedom to operate?

Ergoloid mesylates is the generic ingredient in eight branded drugs marketed by Novartis, Mutual Pharm, Sun Pharm Industries, Watson Labs, Sandoz, 3M, Bristol Myers Squibb, Kv Pharm, Lederle, Superpharm, Vangard, and Ivax Pharms, and is included in thirty-four NDAs. Additional information is available in the individual branded drug profile pages.

There are four drug master file entries for ergoloid mesylates. One supplier is listed for this compound.

Summary for ergoloid mesylates

US Patents:	0
Tradenames:	8
Applicants:	12
NDAs:	34
Drug Master File Entries:	4
Finished Product Suppliers / Packagers:	1
Clinical Trials:	2
Patent Applications:	94
Drug Prices:	Drug price trends for ergoloid mesylates
DailyMed Link:	ergoloid mesylates at DailyMed

See drug prices for ergoloid mesylates

Recent Clinical Trials for ergoloid mesylates

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Elizabeth Berry-Kravis	Phase 2
Sinphar Pharmaceutical Co., Ltd	Phase 2

See all ergoloid mesylates clinical trials

Medical Subject Heading (MeSH) Categories for ergoloid mesylates

Adrenergic alpha-Antagonists
Nootropic Agents
Vasodilator Agents

Anatomical Therapeutic Chemical (ATC) Classes for ergoloid mesylates

C04AE	Ergot alkaloids
C04A	PERIPHERAL VASODILATORS
C04	PERIPHERAL VASODILATORS
C	Cardiovascular system

US Patents and Regulatory Information for ergoloid mesylates

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Superpharm	ERGOLOID MESYLATES	ergoloid mesylates	TABLET;SUBLINGUAL	089234-001	Sep 23, 1986		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
3m	CIRCANOL	ergoloid mesylates	TABLET;SUBLINGUAL	085809-001	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Bristol Myers Squibb	DEAPRIL-ST	ergoloid mesylates	TABLET;SUBLINGUAL	085020-002	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for ergoloid mesylates

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Novartis	HYDERGINE LC	ergoloid mesylates	CAPSULE;ORAL	018706-001	Jan 18, 1983	⤷ Sign Up	⤷ Sign Up
Novartis	HYDERGINE	ergoloid mesylates	SOLUTION;ORAL	018418-001	Approved Prior to Jan 1, 1982	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.